Quick Answer
Longevity Health Holdings, Inc. reported Cash and Equivalents of $706.7 thousand for fiscal year 2025.
Longevity Health Holdings, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $706.7K | +349.8% |
| 2024 | $157.1K | -79.7% |
| 2021 | $774.2K | — |
| 2021 | $0.00 | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| March 31, 2022 | $594.7K | — | -23.2% |
| December 31, 2021 | $774.2K | — | -8.9% |
| September 30, 2021 | $849.6K | — | — |
| June 30, 2021 | $0.00 | — | — |
| January 31, 2021 | $0.00 | — | — |
- Longevity Health Holdings, Inc. showed an increase of +349.8% in Cash and Equivalents compared to the prior fiscal year.
- The most recent figure is from Longevity Health Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: